Adaptive Biotechnologies Corp — Form 4
Filed August 19, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 54/100
What the filing says
Director NEUPERT PETER M (ADPT) sold 140K shares (~$3.1M) on the open market (52% of holdings). Large sale — ~52% of holdings.
Why this rating
Large sale — ~52% of holdings.
See more from August 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.